Amgen S.r.l., a prominent player in the biotechnology industry, is headquartered in Italy and operates extensively across Europe. Founded in 1980, Amgen has established itself as a leader in the development of innovative therapies, particularly in the fields of oncology, nephrology, and inflammation. The company is renowned for its core products, including biologics and biosimilars, which are distinguished by their cutting-edge research and development processes. Amgen's commitment to scientific excellence has led to significant milestones, including numerous FDA approvals and a robust pipeline of therapies that address unmet medical needs. With a strong market position, Amgen S.r.l. continues to make notable contributions to healthcare, driven by its mission to improve patient outcomes through advanced biopharmaceutical solutions.
We don't have data for Amgen S.r.l., but we can show you information about their parent organization instead.
View parent company